Erik J. Sontheimer

Erik J. Sontheimer

Auto-generated profile, based on publicly available information

Erik J. Sontheimer

RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, USA

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2009 in Cell
Verified
Journal Article
Closed access
RCRichard W. Carthew
Richard W. Carthew
ESErik J. Sontheimer
Erik J. Sontheimer

19 December 2008 in Science
Verified
Journal Article
Closed access
PDF file
LMLuciano A. Marraffini
Luciano A. Marraffini
ESErik J. Sontheimer
Erik J. Sontheimer
Horizontal gene transfer (HGT) in bacteria and archaea occurs through phage transduction, transformation, or conjugation, and the latter is particularly important for the spread of antibiotic resistance. Clustered, regularly interspaced, short palindromic repeat (CRISPR) loci confer sequence-directed immunity against phages. A clinical isolate of Staphylococcus epidermidis harbors a CRISPR spacer that matches the nickase gene present in nearly all staphylococcal conjugative plasmids. Here we show that CRISPR interference prevents conjugation and plasmid transformation in S. epidermidis . Insertion of a self-splicing intron into nickase blocks interference despite the reconstitution of the target sequence in the spliced mRNA, which indicates that the interference machinery targets DNA directly. We conclude that CRISPR loci counteract multiple routes of HGT and can limit the spread of antibiotic resistance in pathogenic bacteria.

1 April 2004 in Cell
Verified
Journal Article
Closed access
YLYoung Sik Lee
Young Sik Lee
KNKenji Nakahara
Kenji Nakahara
JPJohn W Pham
John W Pham
KKKevin Kim
Kevin Kim
ZHZhengying He
Zhengying He
RCRichard W Carthew
Richard W Carthew

2 February 2010 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
LMLuciano A. Marraffini
Luciano A. Marraffini
ESErik J. Sontheimer
Erik J. Sontheimer

13 January 2010 in Nature
Verified
Journal Article
Open access
PDF file
LMLuciano A. Marraffini
Luciano A. Marraffini
ESErik J. Sontheimer
Erik J. Sontheimer
Bacteria and archaea that take up exogenous DNA are equipped with host immunity systems that can recognize and eliminate the foreign DNA. One such system is mediated by the CRISPR genes, which encode small RNAs (crRNAs). CRISPR loci consist of repeats and spacer sequences. When the crRNA spacer sequence pairs with complementary invading DNA, it is marked for elimination. Luciano Marraffini and Erik Sontheimer resolve how the spacer DNA within the CRISPR loci themselves is not recognized as foreign; sequences outside the spacer show perfect pairing to the crRNAs while invading DNA will have mismatches. Differential complementarity of this type may underlie many types of self/non-self recognition — a key function in all immune systems. Distinguishing self from non-self is a vital function for immune systems to repel invaders without inducing autoimmunity. One system, which protects bacteria and archaea from invasion by phage and plasmid DNA, involves clustered, regularly interspaced, short palindromic repeat (CRISPR) loci. Here, in Staphylococcus epidermidis, the mechanism of CRISPR self/non-self discrimination is defined. All immune systems must distinguish self from non-self to repel invaders without inducing autoimmunity. Clustered, regularly interspaced, short palindromic repeat (CRISPR) loci protect bacteria and archaea from invasion by phage and plasmid DNA through a genetic interference pathway1,2,3,4,5,6,7,8,9. CRISPR loci are present in ∼40% and ∼90% of sequenced bacterial and archaeal genomes, respectively10, and evolve rapidly, acquiring new spacer sequences to adapt to highly dynamic viral populations1,11,12,13. Immunity requires a sequence match between the invasive DNA and the spacers that lie between CRISPR repeats1,2,3,4,5,6,7,8,9. Each cluster is genetically linked to a subset of the cas (CRISPR-associated) genes14,15,16 that collectively encode >40 families of proteins involved in adaptation and interference. CRISPR loci encode small CRISPR RNAs (crRNAs) that contain a full spacer flanked by partial repeat sequences2,17,18,19. CrRNA spacers are thought to identify targets by direct Watson–Crick pairing with invasive ‘protospacer’ DNA2,3, but how they avoid targeting the spacer DNA within the encoding CRISPR locus itself is unknown. Here we have defined the mechanism of CRISPR self/non-self discrimination. In Staphylococcus epidermidis, target/crRNA mismatches at specific positions outside of the spacer sequence license foreign DNA for interference, whereas extended pairing between crRNA and CRISPR DNA repeats prevents autoimmunity. Hence, this CRISPR system uses the base-pairing potential of crRNAs not only to specify a target, but also to spare the bacterial chromosome from interference. Differential complementarity outside of the spacer sequence is a built-in feature of all CRISPR systems, indicating that this mechanism is a broadly applicable solution to the self/non-self dilemma that confronts all immune pathways.

12 August 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ZHZhonggang Hou
Zhonggang Hou
YZYan Zhang
Yan Zhang
NPNicholas E. Propson
Nicholas E. Propson
SHSara Howden
Sara Howden
LCLi-Fang Chu
Li-Fang Chu
JTJames A. Thomson
James A. Thomson
Significance: Genome engineering in human pluripotent stem cells holds great promise for biomedical research and regenerative medicine, but it is very challenging. Recently, an RNA-guided nuclease system called clustered, regularly interspaced, short palindromic repeats (CRISPR)/CRISPR-associated (Cas) has been applied to genome engineering, greatly increasing the efficiency of genome editing. Here, using a CRISPR-Cas system identified in Neisseria meningitidis , which is distinct from the commonly used Streptococcus pyogenes system, we demonstrate efficient genome engineering in human pluripotent stem cells. Our study could have a tremendous impact in regenerative medicine.